Holowatz, Lacy A <br/><br/>
Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans.  [electronic resource] 

 -  The Journal of physiology  Apr 2011 
 - 2093-103 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1469-7793 
<br/><br/><label>Standard No.: </label>10.1113/jphysiol.2010.203935  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Analysis of Variance<br/>Arginase--antagonists & inhibitors<br/>Arginine--metabolism<br/>Atorvastatin<br/>Biomarkers--blood<br/>Biopsy<br/>Blood Flow Velocity<br/>Cholesterol--blood<br/>Down-Regulation<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Heptanoic Acids--administration & dosage<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Hypercholesterolemia--blood<br/>Lipoproteins, LDL--blood<br/>Male<br/>Microcirculation--drug effects<br/>Microdialysis<br/>Middle Aged<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase Type III--antagonists & inhibitors<br/>Pennsylvania<br/>Pyrroles--administration & dosage<br/>Regional Blood Flow<br/>Skin--blood supply<br/>Time Factors<br/>Treatment Outcome<br/>Triglycerides--blood